Trial Profile
An Open-label, Randomized, Single-dose, 3-period Replicated Crossover Study to Compare the Pharmacokinetics and Safety Following Administration of CJ-30061 Alone and Co-administration of Amlodipine/Valsartan and Atorvastatin in Healthy Adult Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 16 Jul 2020
Price :
$35
*
At a glance
- Drugs Amlodipine/atorvastatin/valsartan (Primary) ; Amlodipine/valsartan; Atorvastatin
- Indications Hyperlipidaemia; Hypertension
- Focus Pharmacokinetics
- Sponsors CJ HealthCare; HK inno.N
- 10 Sep 2018 New trial record